Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04093700 · ClinicalTrials.gov registry record
MDR SureLock All-Suture Anchor
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 24
- Enrollment target
NCT04093700: Clinical Trial study, sponsored by Zimmer Biomet.
NCT04093700 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04093700 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
To report the outcomes of a series of patients with recurrent anterior and/or posterior shoulder instability who underwent surgical repair of the affected labrum using the SureLock all-suture anchor.
Primary Outcome
Patients undergoing isolated anterior or posterior glenoid labrum repair using the SureLock All-Suture Anchor will experience statistically significant improvement in shoulder function assessed through the Western Ontario Shoulder Instability Index (WOSI) outcome measure. The WOSI is a 21-item scale used to measure shoulder related quality of life in patients with symptomatic shoulder instability.
Interventions
- DEVICE SureLock All-Suture Anchor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-11-05 |
| Est. Completion | 2022-11-08 |
Why NCT04093700 stopped before completion
NCT04093700 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SureLock All-Suture Anchor is the first listed.
NCT04093700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04093700 about?
NCT04093700 is a clinical study titled "MDR SureLock All-Suture Anchor". To report the outcomes of a series of patients with recurrent anterior and/or posterior shoulder instability who underwent surgical repair of the affected labrum using the SureLock all-suture anchor.
What is the current status of trial NCT04093700?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2019-11-05. Estimated completion is 2022-11-08.
What interventions are being tested in trial NCT04093700?
The interventions under investigation include: SureLock All-Suture Anchor (DEVICE).
Who is sponsoring clinical trial NCT04093700?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI